γδT cells and CD1d, novel immune players in alcoholic and nonalcoholic steatohepatitis?
Alcoholic and non-alcoholic fatty liver diseases (NALFD) have emerged as the leading causes of chronic liver diseases worldwide, having a similar continuum of disorders ranging from simple steatosis to steatohepatitis, cirrhosis, and hepatocellular carcinoma. Inflammation plays an important role in controlling alcoholic steatohepatitis (ASH) and nonalcoholic steatohepatitis (NASH) development and progression, but the exact contribution of immune cells that triggers progression from simple steatosis to steatohepatitis is still obscure.